Henry Ottilie Institut für Pharmakologie, Pharmazie und Toxikologie,

Slides:



Advertisements
Similar presentations
Consider a career in large animal veterinary practice.
Advertisements

“One Health” pulling Animal Health and Public Health together
Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.
APIs – global business developments Gian Mario Baccalini EFCG Board Member, Chairman of EFCG Pharma Business Committee President, B&P Development Srl,
SCHEDULING OF MEDICINES SAPRAA 13 June Scheduling of Medicines Ephedrine Pseudoephedrine D-nor-pseudoephedrine.
Challenges for Lithuanian health system: EU accession Rytis Virbalis, MD, MPH, Senitor adviser to Committee on Health affairs Lithuanian Parliament 1.Prevention.
UEVP is a section of the Federation of Veterinarians of Europe UEVP GA – BRUXELLES 2010 NOVEMBER 11th REPORT ON FUTURE MEAT INSPECTION Thierry CHAMBON,
Introduction to Regulation
Ministry of Agriculture of the Czech Republic Food Safety in the Czech Republic.
Food Safety Systems in some Member States of the European Union Dieter Arnold Berlin Dieter Arnold
Sabena Ahmad Iveta Smincakova Dawn Bradbury. Political:  Lighter Regulatory Controls (1960s)  Tighter Regulatory Controls on Clinical trials (1970s)
EMEA / IFAH–Europe Info Day « Balancing the benefits and risks of Veterinary Medicinal Products »
UEVP is a section of the Federation of Veterinarians of Europe Union européenne Des vétérinaires praticiens Internet sales of.
KNOWLEDGE FOR LIFE Veterinary Information to Strengthen the Livestock and Dairy Sector in India: An International Consultation Robert Taylor.
FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.
Creating Trust in Critical Network Infrastructures Canadian Case Study Michael Harrop.
Market Surveillance in Germany 1 Forum on Market Surveillance 29 October in Geneva Dr. Christoph Brandt Chairman of the Working Committee for Market Surveillance.
 Pharmacovigilance – Patient’s standpoint Steve Arlington May 2007.
> In April of 2007, Main Pharmaceutical Inspector created special position for combating counterfeit and illegal medicines > In May,
1 Establishing a Pharmacovigilance Centre Sten Olsson the Uppsala Monitoring Centre.
Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.
STRATEGIC MANAGEMENT 1 Irina Raynaud Pierre Jean Tessier Nicolas Cabrit Clément Tumoine.
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA. Presentation by: Dr. Joseph K. Yano B.Pharm (Nbi) L.L.B (Moi) Legal Officer Pharmacy and Poisons Board Ministry.
The South African perspective
Pharmacovigilance Programme of India
Tanzania Aflatoxin Workshop December 3 and 4, 2012 Collaboration across Ministries of Health, Agriculture and Livestock to enhance dietary diversity and.
SMMSS - Support to Modernisation of Mongolia Standardisation System Organization of Food Control Systems Example Local Authority - DE - Seminar on Food.
Federal Food, Drug, and Cosmetic Act 1938, 1954, 1958 (FFDCA) Katie Buhai Period 3.
MEDICAL RESOURCES FOR PET HEALTH Mary L. Westermann April 5, 2011 RASD/NCLA.
Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Role of Regulation in Optimizing Medicine use KNH/UON Pharmacy Symposium Optimizing Medicine.
September 13, 2007SGH&M2B International&Training Workshop What does the European Technology Platform “Innovative Medicines initiative” offer? Vitalijs.
Pharmacovigilance of Nutraceutical Products
THE ITALIAN ICT MARKET Maura Gritti - International Operations Director.
Food Laws and Food Control Management Structures – the Polish Perspective Aleksandra Wesołowska Polish Consumers Association.
Review of veterinary medicines legislation in 2010 Mario Nagtzaam Unit F2 „Pharmaceuticals“ Directorate-General Enterprise and Industry European Commission.
Dr Shanthi Pal Quality Assurance and Safety of Medicines WHO
Executive Department for Communication and Awareness (Business Sector) Mr. Abdulrahman Algifari Communication and Awareness Executive Director.
Research Animal Welfare & Scientific Integrity: An AAALAC International Perspective John F. Bradfield, DVM, PhD, DACLAM Senior Director, AAALAC International.
Event labelled by the EU Belgian Presidency CONCLUSIONS.
Minimum requirements for Pharmacovigilance in countries.
PHARMACOVIGILANCE PLAN FOR TANZANIA PREPARED BY EMMA & MARY 10 TH SEPTEMBER 2004.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
FDA Risk Communication Nancy M. Ostrove, PhD Senior Advisor for Risk Communication Risk Communication Advisory Committee February 28, 2008.
PharmacoVigilance: Development of PhV systems and processes.
EPHA Presentation Healthcare and social services treated equally as estate agents or advertising companies excluded from the Directive or Healthcare and.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
1 VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER 2015, TOKYO VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER.
PharmacoVigilance: Development of PhV systems and processes VICH Workshop, Dar Es Salaam, Tanzania, 24 June 2015.
Global Nutraceuticals Industry Analysis till 2017 – Emerging Markets in Asia-Pacific and Latin America to Drive Growth provides a comprehensive analysis.
1 Pharmacovigilance & the New National Adverse Drug Reaction (ADR) Reporting System Michael Bonett, Quality Assessor Post-Licensing Directorate Medicines.
REGULATION (EC) Nº 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 30 November 2009 on cosmetic products 1 Shall apply from 11.
Sustainable Companies for the 21st Century Evolution of the Components of Sustainability for GlaxoSmithKline Dr. James Hagan Vice President Corporate Environment,
1 PHARMACOVIGILANCE & THE NATIONAL ADVERSE DRUG REACTION (ADR) REPORTING SYSTEM Sarah Spiteri Post-Licensing Directorate Medicines Authority.
Waiving TABST for vaccines Argentina: Not an allowed procedure today Require batch safety tests in laboratory animals, repeated by authorities Currently.
Best 3D Services In India | 3d servicesIndia
The importance of drug take-back programs: protecting our health and environment [TEMPLATE PRESENTATION] prepared by the product stewardship institute.
Change in legislation on alcohol, tobacco and drugs in Russia in 2016.
The importance of drug take-back programs: protecting our health and environment [TEMPLATE PRESENTATION] prepared by the product stewardship institute.
The importance of dialogue between regulators
EU animal health rules for moving dogs and cats into a Member State from another Conference on identification, vaccination and movement of dogs and cats.
The Role of the Private Vet
National Medicines Policies
Medicines Safety Mary R. Couper
Patient Involvement in the Development and Safe Use of
All Professionals are involved in
Transformation in Occupational Health and Safety systems: countries that newly entered the EU – lessons learnt Dr. Ivan Kokalov, Vice-President Confederation.
National Medicines Policies
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA
Global Artificial Sweetener Market. According to the report “Artificial Sweeteners Market, Consumption & Forecast, By Products, Regions, Applications,
Interconnection of good practices: from development to distribution
Presentation transcript:

VETIDATA – A web based information system on veterinary medicinal products and legislation Henry Ottilie Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät, Universität Leipzig

What is VETIDATA? Information centre for vets legal provisions drug/vaccine informations lists of substances (essential for treatment of equidae, for use in food producing animals)

Who uses? More than 6000 users research institutes pharmaceutical industries veterinarians associations and authorities practitioners students

Information flow Federal Office for Consumer Protection and Food Safety Pharmaceutical companies VETIDATA Vets University/current research results Current legislation (EU, Germany)

Communication channels Telephone E-Mail Fax Internet

Users feedback very rare only in case of possible liability of the vet Reasons Time? No risk awareness? Differences between countries? – Why?

Current project in pharmacovigilance repeated requests personal face-to-face contact permanent sensitation to the topic of adverse reactions (How) Is it possible to enhance the consciousness for pharmacovigilance?

Questions (When) Will product safety become critical selling point/product feature for veterinary drugs? Which company/drug will survive?

Answer „Pharmacovigilance is an important issue of public health and the government appreciate its need for the common citizen.” Dr. M. Hamid Ansari, Vice President of India New Delhi, Nov. 26, 2010 India: 1.2 Billion inhabitants, second most populous country in the world Europe and North and Middle Amerika: all in all 1.2 Billion inhabitants